Enable biotech innovators to deliver effective precision medicine solutions that are clinically credible, operationally scalable, and quality driven.
Leading innovation ecosystems where scientific excellence is matched by disciplined execution, accelerating patient impact and partner confidence.
My work bridges science, laboratory operations, quality systems, and regulatory expectations. I operate as a hands-on strategic partner, defining clear pathways, de-risking execution, and building defensible systems that hold up under clinical scrutiny, audits, and diligence.
My style is pragmatic and outcomes-focused: establish credibility early, align teams around execution, and ensure that innovation translates into real-world clinical and commercial value.
Sherif holds a PhD in molecular biology, is completing an MBA, and is a certified Project Management Professional (PMP). He brings a disciplined yet flexible leadership style well suited to growth-stage biotech companies seeking fractional executive support or targeted advisory expertise.
Dr. Sherif Louis is a biotech and diagnostics executive with over 20 years of experience spanning clinical operations, laboratory leadership, quality systems, partnerships, and intellectual property strategy. He has led multidisciplinary teams across academia, healthcare institutions, and industry, with a focus on translating complex science into clinically and operationally robust diagnostic programs.
His work has included the design and execution of diagnostic clinical studies, establishment of accreditation-aligned laboratory systems, development of quality management frameworks, engagement with key opinion leaders, and strategic positioning of diagnostic IP. He has contributed to peer-reviewed publications and international collaborations in precision oncology and biomarker-driven medicine.
Sherif holds a PhD in molecular biology, is completing an MBA, and is a certified Project Management Professional (PMP). He brings a disciplined yet flexible leadership style well suited to growth-stage biotech companies seeking fractional executive support or targeted advisory expertise.
